According to Travere Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 04:06 PM, company Senior Vice President, R&D, Rote William E. disclosed selling 2,500 shares at a cost of $27.40. At the time of this transaction (Jan 11), this trade was worth $68,500 […]
According to Homology Medicines, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 04:05 PM, company CFO & Treasurer, Smith W Bradford disclosed selling 2,182 shares at a cost of $3.78. At the time of this transaction (Jan 05), this trade was worth $8,248 in […]
According to FATE THERAPEUTICS INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 04:05 PM, company Chief R&D Officer, Valamehr Bahram disclosed selling 5,596 shares at a cost of $46.38. At the time of this transaction (Jan 10), this trade was worth $259,558 in total. […]
According to Homology Medicines, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 04:05 PM, company Chief Operating Officer, Kelly Timothy P disclosed selling 1,406 shares at a cost of $3.78. At the time of this transaction (Jan 05), this trade was worth $5,315 in […]
According to Homology Medicines, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 04:05 PM, company Chief Scientific Officer, Seymour Albert disclosed selling 1,661 shares at a cost of $3.78. At the time of this transaction (Jan 05), this trade was worth $6,279 in total. […]
According to Travere Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 04:05 PM, company Chief Financial Officer, Clague Laura disclosed selling 7,500 shares at a cost of $27.40. At the time of this transaction (Jan 11), this trade was worth $205,500 in total. […]
According to Homology Medicines, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 04:05 PM, company Chief Medical Officer, Cohn Gabriel disclosed selling 1,661 shares at a cost of $3.78. At the time of this transaction (Jan 05), this trade was worth $6,279 in total. […]
According to Homology Medicines, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 04:05 PM, company President & CEO, Tzianabos Arthur disclosed selling 5,354 shares at a cost of $3.78. At the time of this transaction (Jan 05), this trade was worth $20,239 in total. […]
According to NORTH EUROPEAN OIL ROYALTY TRUST’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 03:56 PM, company Managing Trustee, Adelman Robert P disclosed selling 4,000 shares at a cost of $11.41. At the time of this transaction (Jan 12), this trade was worth $45,649 […]
According to RICHARDSON ELECTRONICS LTD/DE’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 01:04 PM, company CFO, CAO, Corporate Secretary, Ben Robert J disclosed selling 5,000 shares at a cost of $15.08. At the time of this transaction (Jan 11), this trade was worth $75,400 […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
